Cite
HARVARD Citation
Papaluca, T. et al. (2021). Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics. Clinical infectious diseases. pp. e3288-e3295. [Online].